, 2005), which was also evident in this study (Table 1) We postu

, 2005), which was also evident in this study (Table 1). We postulated that the MDR phenotype of S. pneumoniae isolates with both erm(B) and mef(A) genes may be associated with their high recombination ability. We examined this hypothesis by estimating the recombination frequency of S. pneumoniae isolates. In addition, we estimated the mutation frequency to investigate its relationship with antimicrobial resistance and the dual presence of erm(B) and mef(A)

genes. Here, we demonstrate that mutation frequency was not related with the uptake of MAPK inhibitor both erm(B) and mef(A) genes. In addition, mutators did not showed higher resistance rates than nonmutators in most antimicrobial agents, except in the case of ciprofloxacin (data not shown). In addition, we did not observe an association between hexA and hexB polymorphisms and the mutator phenotype, which agrees with previous observations (Gutiérrez et al., 2004). So far, it has not been established whether mutators are related to the emergence of antimicrobial resistance

in bacteria (Chopra et al., 2003). Studies involving E. coli have suggested that mutators may be related to the acquisition of antimicrobial resistance or to evolution of extended-spectrum β-lactamase (Tanabe et al., 1999; Orentica et al., 2001; Miller et al., 2002). In S. aureus, macrolide resistance is thought to result from selective antibiotic pressure in cystic fibrosis (Prunier et al., 2003). However, a previous study did not Parvulin show any significant correlation between antimicrobial Cyclopamine molecular weight resistance and hypermutable phenotype, although it did identify a high frequency of S. pneumoniae mutator phenotype from patients with cystic fibrosis (del Campo et al., 2005). In addition, an association between hypermutation and antimicrobial resistance was not observed in P. aeruginosa (Gutiérrez et al., 2004). On the contrary, pneumococcal isolates

with both erm(B) and mef(A) genes displayed a high recombination frequency in this study which was statistically significantly higher than that of isolates possessing only the mef(A) gene and erythromycin-susceptible isolates. Although not significant, their recombination frequency was also higher than that of isolates possessing only the erm(B) gene. In addition, all four isolates showing the hyper-recombination phenotype (recombination frequency >10−4) contained both the erm(B) and mef(A) genes. Although these four isolates with the hyper-recombination phenotype did not show a significantly higher antimicrobial resistance rate, probably due to the limited number of isolates examined (data not shown), pneumococcal isolates with both erm(B) and mef(A) genes exhibited significantly higher resistance rates than isolates of other groups in most antimicrobial agents (Table 1).

HIV monitoring What baseline tests should be recommended for HIV-

HIV monitoring What baseline tests should be recommended for HIV-positive women? How often should they be repeated? How should we investigate and manage abnormal liver function in pregnancy? Sexual health When should we recommend sexual health screening and how often? How should we manage genital infections in HIV-positive

pregnant women? “
“We are writing to restate the position of the Paediatric European Network for Treatment of AIDS (PENTA) on recommended thresholds for initiating antiretroviral FGFR inhibitor therapy (ART) in children, following the recent publication of updated World Health Organization (WHO) guidance [1]. PENTA continues to recommend that paediatricians in Europe use the thresholds in the 2009 PENTA guideline for use of ART in children [2], and sees no conflict between this and the updated WHO guidance. The PENTA guideline thresholds may also be appropriate for middle-income countries outside Europe where regular follow-up with clinical and CD4 cell count monitoring is possible. Both the PENTA 2009 and WHO 2010 guidelines recommend starting ART in all infants below 12 months,

in all children with significant symptoms (WHO stage 3 or 4), and in asymptomatic children from age 5 years onwards at the same CD4 threshold as adults, i.e. 350 cells/μL. For asymptomatic children between ages 1 and 5 years, PENTA 2009 and previous WHO 2008 guidance [3] Ruxolitinib cell line recommended starting ART according to CD4 cell count in two identical age

bands (12–36 and 36–59 months), albeit at different CD4 levels. The new WHO guidance extends the recommendation for universal treatment from 12 months to 24 months, as well as using lower CD4 thresholds from age 2 to 5 years in a single age band (Table 1). Both PENTA 2009 and WHO 2010 guidelines considered the same body of evidence, and several experts took part in the drafting of both sets of recommendations. The universal treatment of infants is based on evidence from the Children with HIV Early Antiretroviral Therapy (CHER) study [4], a randomized controlled trial (RCT) showing a 76% reduction Liothyronine Sodium in mortality with early initiation of ART. Children over 5 years are treated at adult thresholds in both guidelines, based on similar disease progression rates in children over 5 years and adults in comparisons between the HIV Paediatric Prognostic Markers Collaborative Study (HPPMCS) child cohort and Concerted Action on SeroConversion to AIDS and Death in Europe (CASCADE) adult seroconverter cohort [5,6]. The recommendations for children aged between 2 and 5 years are based on cohort data on disease progression according to age and CD4 cell count, largely from the HPPMCS study [5].

These guidelines have used the British HIV Association (BHIVA) st

These guidelines have used the British HIV Association (BHIVA) standard grading for levels of evidence (see Table 1.1). The translation of data into clinical practice is often difficult even with the best possible evidence (i.e. that from two randomized controlled selleck kinase inhibitor trials) because of trial design, inclusion criteria and precise endpoints. Furthermore, many opportunistic infection treatment studies were performed prior to the availability of HAART. A number of newer diagnostic tests and imaging modalities may help to expedite OI diagnosis and allow earlier initiation of specific therapy with

improved outcomes. Recommendations based upon expert opinion have the least evidence but perhaps provide an important reason for writing the guidelines: to produce a consensual opinion about current practice. It must, however, be appreciated that such opinion is not always correct and alternative practices may be equally valid. The recommendations contained in these guidelines should therefore be viewed as guidelines in the true spirit of the term. They are not designed to be restrictive nor should they challenge

research into current practice. Similarly, although the BHIVA Opportunistic Infection Guidelines Group seeks to provide guidelines to optimize treatment, such care needs to be individualized and we have not constructed a document BAY 80-6946 nmr that we would wish to see used as a ‘standard’ for litigation. The impact

of HAART in preventing opportunistic infection is well established. Whilst HAART is the cornerstone of treatment that leads to resolution or improvement in certain L-NAME HCl OIs, co-prescription of HAART with specific OI treatment is complicated by overlapping toxicities, drug–drug interactions and occasionally a severe immune reconstitution inflammatory syndrome (IRIS), which may complicate the management of both the OI and the underlying HIV infection. Whilst there are limited data with which to provide definitive guidance on when to start HAART in patients with OIs, these guidelines support early initiation of HAART and provide practical information regarding co-prescribing and management of common complications. The clinical care of patients with known or suspected OIs requires a multidisciplinary approach, drawing on the skills and experience of all healthcare professional groups. Moreover, these guidelines emphasize that inpatients with HIV-related disease often need rapid access to a variety of diagnostic tests and radiological interventions that may not be immediately available at local hospitals. Furthermore, expert interpretation of these tests by supporting specialties such as radiology, histopathology, microbiology and virology is often required.


“International Journal of Paediatric Dentistry 2010; 20: 4


“International Journal of Paediatric Dentistry 2010; 20: 419–425 Aim.  To compare the survival rates of Class II Atraumatic Restorative Treatment (ART) restorations placed in primary molars using cotton rolls or rubber dam as isolation methods.

Methods.  A total of 232 children, 6–7 years old, both genders, were selected having one primary molar with proximal dentine lesion. The children were randomly assigned into two groups: control group with Class II ART restoration made using cotton rolls and experimental group using rubber dam. The restorations were evaluated by eight calibrated evaluators (Kappa > 0.8) after 6, 12, 18 and 24 months. Results.  A total of 48 (20.7%) children were considered dropout, after 24 months. Selleck NU7441 The cumulative survival rate after 6, 12, 18 and 24 months was 61.4%, 39.0%, 29.1% and 18.0%, respectively for the control selleck chemicals llc group, and 64.1%, 55.1%, 40.1% and 32.1%, respectively for the rubber dam group. The log rank test for censored

data showed no statistical significant difference between the groups (P = 0.07). The univariate Cox Regression showed no statistical significant difference after adjusting for independent variables (P > 0.05). Conclusion.  Both groups had similar survival rates, and after 2 years, the use of rubber dam does not increase the success of Class II ART restorations significantly. “
“Reduced bond strengths of resin composites to hypomineralised enamel increase restorative failure. To investigate if the adhesion of resin composite to hypomineralised enamel can be improved by pre-treatments: resin infiltration, oxidative pre-treatment followed by a resin infiltration, or oxidative pre-treatment. Twenty-one enamel specimens in each of five Groups: 1) Normal enamel; 2) Hypomineralised enamel; 3) Hypomineralised enamel pre-treated with a resin infiltrant, (Icon®); 4) Hypomineralised enamel pre-treated with 5.25% sodium hypochlorite then treatment with resin infiltrant; 5) Hypomineralised enamel pre-treated with 5.25% sodium hypochlorite. A resin composite rod was bonded to each specimen using Clearfil™ SE bond as the adhesive (hereafter

crotamiton termed ‘routine bonding’), then subjected to microshear bond strength (MSBS) testing. Overall, the mean MSBS between the five groups differed significantly (P = 0.001). Pre-treatment of hypomineralised enamel with 5.25% sodium hypochlorite with or without subsequent resin infiltration in Groups 4 and 5 prior to routine bonding resulted in increased mean MSBS compared to Groups 2 and 3, with mean MSBS values not differing significantly when compared to routine bonding to normal enamel. Increased bond strength of resin composite to hypomineralised enamel was obtained by pre-treatment of hypomineralised enamel specimens with 5.25% sodium hypochlorite with or without subsequent resin infiltration. “
“International Journal of Paediatric Dentistry 2011; 21: 185–191 Aims.

The backward inner primer (BIP) consists of the B1c sequence (com

The backward inner primer (BIP) consists of the B1c sequence (complementary to B1), TTTT and B2 sequence. LAMP was performed in a total 25-μL reaction

mixture containing 1.6 μM of each inner primer (FIP and BIP), 0.2 μM of each outer primer (F3 and B3), 1.4 μM dNTPs and 1 M betaine (Sigma). Each LAMP reaction also included 20 mM Tris-HCl (pH 8.8), 10 mM KCl, 10 mM (NH4)2SO4, 6 mM MgSO4, 0.1% Tween 20, 1.0 μL (8 U) Bst DNA polymerase large fragment (New England BioLabs) and 1 μL of template DNA. The mixture was incubated at 61 °C for 60 min in a water bath and then heated at 80 °C for an additional 10 min to terminate the reaction. The LAMP products Erlotinib nmr were subjected to 2% agarose gel electrophoresis, stained with ethidium bromide and visualized under UV light. On the basis of the restriction maps of the target sequences of LAMP product, AluI was selected for use for restriction analysis. Following overnight digestion

at 37 °C, the digested products (2 μL) were analyzed by electrophoresis in 3% agarose gels stained with ethidium bromide. The LAMP products were also detected by adding 1.0 μL of original SYBR Green I diluted 1000-fold to the tube. The color of the solution was then observed. GSK3 inhibitor The PCR of Angen et al. (2007) was used as the first round of nested PCR. Briefly, 2 μL of template DNA was added to a 48-μL PCR mixture, containing 5 μL of 10 × PCR buffer, 0.15 mM of dNTPs, 65 ng each of the oligonucleotide primers HP1F3 and HP2F2, 130 ng of primer HP-Revx and 1.0 U Tag polymerase (Fermentas Inc.). In the second round of nested PCR, 2 μL of undiluted first-round PCR

product was added to a 48-μL PCR mixture, similar to the first-round PCR, but containing 130 ng of F3 and B3 primers. Both rounds were run under the following conditions: 35 cycles of denaturation at 94 °C for 1 min, annealing at 56 °C for 45 s, extension at 72 °C for 1 min and a final extension at 72 °C for 7 min. PCR reactions were performed using the GeneAmp PCR System 9700 (Applied Biosystems). The sensitivity of the LAMP and nested PCR tests was compared using a pure culture of H. parasuis serovar 5 Nagasaki strain, pericardial fluid (PF) spiked with the same strain and lung tissue homogenate spiked with the same strain, respectively. A suspension of the pure culture of H. parasuis serovar 5 Nagasaki strain was adjusted to 8 × 109 CFU mL−1 as measured Resveratrol by triplicate plate counts. The suspension was then diluted in a 10-fold series in PBS to give dilutions containing 8 × 100–8 × 108 CFU mL−1 and 0.3 mL of each dilution was added to 2.7 mL sterile water, PF or lung tissue homogenate, respectively. Then the cells were heat treated in a boiling water bath for 10 min and centrifuged at 13 400 g for 10 min. As the template for the LAMP and nested PCR, 1 and 2 μL of the resulting supernatant containing extracted DNA was used, respectively.

A large outbreak of

A large outbreak of Selleckchem JAK inhibitor meningococcal meningitis has been reported in the years 1987 and 2000.1,2 Tuberculosis has been reported as one of the most common causes of lung infection that requires hospitalization during hajj.3 The hajj pilgrims are also having high risk to contract hepatitis.4 Other reported communicable diseases include diarrheal disease, skin infection, and emerging infectious agents.5 Respiratory diseases are a common illness during hajj season and respiratory tract infections are the commonest

cause of hospital admission during hajj.6 Pneumonia alone was the most common cause for hospital admission which accounted for 39.4% in 2002 and 19.7% in 2003 hajj season, respectively.7,8 In 2004 hajj season, pulmonary diseases like pneumonia, pulmonary edema, chronic obstructive pulmonary disease (COPD), and bronchial asthma were the Selleckchem Antiinfection Compound Library next commonest admission to intensive care units after myocardial

infarction. Pneumonia contributed to 22.1% of intensive care admission.9 The previous study among Malaysian hajj pilgrims was in 2000 hajj season on the effectiveness of influenza vaccination to reduce respiratory symptoms.10 However, this study was not about the prevalence of respiratory symptoms among Malaysian hajj pilgrims in general and the recruitment of the subjects was based on clinic attendance. Therefore, the aim of this study was to determine the prevalence of specific acute respiratory symptoms among Malaysian hajj pilgrims. The effect of a few protective measures taken by hajj pilgrims to reduce respiratory symptoms was determined. A cross-sectional study was conducted among Malaysian hajj pilgrims in the 2007 hajj season. Survey forms were distributed at Madinatul-Hujjaj, Jeddah, and Tabung Haji Clinic, Medina where pilgrims stay on transit before returning Lck to Malaysia. The survey form was in Malay

language and designed to be self administered. The response was on a voluntary basis. The respondents returned the completed survey forms to the collection box located at the clinic in Madinatul-Hujjaj, Jeddah, or Tabung Haji Clinic, Medina. Ethical approval was obtained from USM Research and Ethics Committee prior to the conduct of this study. The calculated sample size was 276 respondents. After including 20% expected dropout, total required minimal sample size was 331. In view of possible low response rate in a voluntary self-administered survey and a very busy situation, 2,000 survey forms were distributed at the transit center. The specific respiratory symptoms, namely cough, sore throat, runny nose, and fever were analyzed in detail to determine the effect of protective measures taken by Malaysian hajj pilgrims. Influenza-like illness (ILI) was defined as the triad of cough, subjective fever, and sore throat as suggested by Rashid et al.11 Data were entered and analyzed using spss software (SPSS, Chicago) version 12.0.

We have described the fabrication of highly versatile devices tha

We have described the fabrication of highly versatile devices that allow for the simultaneous recording of large numbers of neurons and the optical activation or silencing of select subpopulations of neurons within the recorded area. These devices can be used in any brain area that is accessible to thin silicon probes, and are suitable for both anesthetized and awake recording conditions in behaving animals. When paired with the expression of light-sensitive actuators within genetically specified neuronal populations,

these devices allow the relatively straightforward and interpretable manipulation of network activity. Future development of optoelectronic probes may include the use of light-emitting diode (LED)-coupled fibers, waveguides for light in the silicon probe substrate and on-site organic-LEDs, selleck combined to further Obeticholic Acid supplier decrease probe volume. This work was supported by the Howard Hughes Medical Institute. We thank T. Adelman, S. Bassin, J. Osborne and T. Tabachnik for their technical contribution, and G. Shtengel and D. Huber for useful discussions. Abbreviations AAV adenoassociated virus ChR2 channelrhodopsin-2 GFP green-fluorescent protein NpHR halorhodopsin PV

parvalbumin “
“We review the history of efforts to apply central thalamic deep brain stimulation (CT/DBS) to restore consciousness in patients in a coma or vegetative state by changing the arousal state. Early experimental and clinical studies, and the results of a recent single-subject human study that demonstrated both immediate behavioral facilitation and carry-over effects of CT/DBS are reviewed. We consider possible mechanisms underlying CT/DBS effects on cognitively-mediated behaviors in conscious patients in light of the anatomical connectivity and physiological specializations of the central thalamus. Immediate and carry-over effects of CT/DBS are discussed

within the context of possible effects on neuronal plasticity and gene expression. We conclude that CT/DBS should be studied as a therapeutic intervention to improve impaired cognitive function in severely brain-injured patients who, in addition to demonstrating clinical evidence of consciousness Rho and goal-directed behavior, retain sufficient preservation of large-scale cerebral networks within the anterior forebrain. Although available data provide evidence for proof-of-concept, very significant challenges for study design and development of CT/DBS for clinical use are identified. “
“In the last 10 years, many studies have reported that neural stem/progenitor cells spontaneously produce new neurons in a subset of adult brain regions, including the hippocampus, olfactory bulb (OB), cerebral cortex, substantia nigra, hypothalamus, white matter and amygdala in several mammalian species. Although adult neurogenesis in the hippocampus and OB has been clearly documented, its occurrence in other brain regions is controversial.

1) Sequences of nonheterocyst-forming unicellular and filamentou

1). Sequences of nonheterocyst-forming unicellular and filamentous VX-809 datasheet cyanobacteria of groups I, II and III were used as outgroups. The 16S rRNA genealogy revealed four clades. Clade I was formed by the unicellular genera Synechococcus,

Prochlorococcus and the filamentous genus Phormidium; clade II contained all cyanobacterial sequences originating from Pozas Azules, a desert pond in northern Mexico, plus three sequences assigned to Rivularia from the Baltic Sea (AM230665, AM230675), Baja, Mexico (AM230677) and one sequence (AY493597) assigned to Calothrix from Antarctica, which we propose belongs to the genus Rivularia. Clade III grouped the sequences of Tolypothrix PCC 7504 originating from the Baltic Sea, Tolypothrix AB093486, Calothrix AB074504, from Palau island, which we propose to be a Tolypothrix, Anabaena variabilis and Nostoc PCC 7120. Clade IV

was a Calothrix clade, and included all sequences from the Baltic Sea and the strain PCC 7103. The cyanobacterial sequences from Heron Island (Australia) grouped more closely to Rivularia, although they showed enough genetic distance to be considered as a separate clade. Recent molecular-based analysis has attempted to disentangle the evolutionary relationships between Calothrix and closely related genera (Hongmei et al., 2005; HCS assay Sihvonen et al., 2007; Berrendero et al., 2008). Using a region of the 16S rRNA gene, strains morphologically identified as Calothrix were found to be representatives of Gloeotrichia and Tolypothrix (Sihvonen et al., 2007). Further, the work of Berrendero et al. (2008) suggest a phylogenetic analysis that strains from calcareous rivers and streams attributed based on morphological traits to Calothrix actually pertain to Rivularia, a genus that has been proposed to be extremely abundant in calcareous

freshwater habitats (Pentecost & Whitton, 2000). Nevertheless, due to differences between morphologic and phylogenetic classifications, Sihvonen et al. (2007) and Berrendero et al. (2008) supported the idea that the genus Calothrix is polyphyletic and suggested that it should be divided into different genera. Berrendero et al. (2008) also suggested that Rivularia is not monophyletic. Ribonucleotide reductase In contrast to the above, our Bayesian phylogenetic inference analyses showed a robust separation of Calothrix and Rivularia, suggesting that they represent monophyletic genera (Figs 1 and 2). The sequences obtained in the present study for the strains Calothrix PCC 7103 and Tolypothrix PCC 7504 were found to be heterogenous (Fig. 1), and are clearly monophyletic, showing the interspecific divergence of these strains. It is also clear from our data that Tolypothrix and Gloeotrichia constitute phylogenetic groups with imprecise demarcations according to existing sequences in public databases.

, 2005; Khedr et al, 2005;

Kim et al, 2006; Talelli et 

, 2005; Khedr et al., 2005;

Kim et al., 2006; Talelli et al., 2007; Sparing et al., 2009). Moreover, anatomical and functional evidence supports the notion that perilesional tissue is a key component for reorganization and plasticity, leading to behavioral improvements after focal brain damage (Nudo, 1999, 2006; Mittmann http://www.selleckchem.com/products/PD-0332991.html & Eysel, 2001; Werhahn et al., 2003). Accordingly, we tested the hypothesis that a direct manipulation of perilesional tissue activity in multiple sessions would maximize the magnitude and duration of the pursued therapeutic outcomes. Indeed, our findings confirm that in spite of inter-individual variability, high-frequency perilesional rTMS stimulation is capable of recovering real-space visuospatial function in chronically brain-damaged individuals. Nonetheless, the discussion on which factors might best account for such variability remains open. Results reveal that the level of spontaneous recovery seems to be the only significant predictor of positive rTMS improvements. More specifically,

low spontaneous recovery levels were associated with little benefit from rTMS rehabilitation in our group of Non-responders, while those with moderate spontaneous recovery prior to rTMS, within the group of Responders, benefited the most from stimulation. A closer inspection of eccentricity-specific recovery values shows Selleck MDV3100 that ameliorations progressed from pericentral to peripheral eccentricities.

Furthermore, Non-responders as opposed to Responders failed to fully recover spontaneously the ability to orient to targets presented at the most pericentral contralesional eccentricity, separated only 15o from fixation. This result suggests that a consistent and complete recovery of this specific spatial location might be essential to recover orienting in further peripheral eccentricities during the spontaneous recovery phase C-X-C chemokine receptor type 7 (CXCR-7) and to show further improvements under neurostimulation. Regardless of where the processing and recovery of 15° took place, it appears that these early-recovered pericentral eccentricities served as a critical visual cue acting as a stepping-stone to facilitate awareness to progressively more eccentric locations within the neglected visual hemispace, increasing overall recovery. Without a doubt, one of the most intriguing aspects of the current study is the existence of contrasting behavioral effects in equally treated animals. Several studies have demonstrated that it is not uncommon to find large levels of inter-individual variability in electrophysiological and behavioral responses of healthy humans to rTMS (Maeda et al., 2000; Maeda & Pascual-Leone, 2003; Gangitano et al., 2002; Bäumer et al., 2003).

However, perinatally infected women have been exposed to ART thro

However, perinatally infected women have been exposed to ART throughout much of their postnatal growth and development. Mitochondrial dysfunction in uninfected infants exposed to ART in foetal life has been reported and, as mitochondria are solely maternally inherited, LY2109761 cost ongoing surveillance of the second generation is needed [16]. It was reassuring that all the births identified by the participating units in this study had also been independently reported to the NSHPC, and were in most cases linked to the mothers’ own paediatric records. However,

long-term follow-up is likely to prove challenging as previous attempts to maintain follow-up of children with in utero exposure to ART experienced Omipalisib research buy difficulties in enrolment and retention [17]. Appropriate support for perinatally infected adolescents requires significant input from the multidisciplinary team to maintain good health and prevent onward transmission of infection to the patients’ sexual partners and offspring. Education around relationships, sexual health and contraception needs to start early in the paediatric clinic in language appropriate to the age and neurocognitive ability of the child and be readdressed during transition and following transfer to adult services. Appropriate adolescent-friendly services that focus on their complex needs are required. Where paediatric healthcare professionals

do not have the sexual health expertise required, provision should be made through Thiamet G close liaison with adult sexual health providers. Timely monitoring of the management and outcome of pregnancies in women with perinatal/early acquired HIV infection is necessary, and should be possible through the established paediatric and obstetric surveillance systems. However, monitoring of the overall

fertility and sexual health of perinatally infected young women and men and the well-being of their uninfected children will be much more challenging, and is likely to require more intensive follow-up of perinatally infected adults and their offspring. This survey was registered with Imperial College Healthcare NHS Trust; ethical approval was not required. The NSHPC has MREC approval (ref. MREC/04/2/009). “
“Objectives The aim of the present study was to assess fluconazole pharmacokinetic measures in serum and cerebrospinal fluid (CSF); and the correlation of these measures with clinical outcomes of invasive fungal infections. Methods A randomized trial was conducted in HIV-infected patients receiving three different regimens of fluconazole plus amphotericin B (AmB) for the treatment of cryptococcal meningitis. Regimens included fluconazole 400 mg/day+AmB (AmB+Fluc400) or fluconazole 800 mg/day+AmB (AmB+Fluc800) (14 days followed by fluconazole alone at the randomized dose for 56 days); or AmB alone for 14 days followed by fluconazole 400 mg/day for 56 days.